These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25405656)

  • 61. Comparison of drug-eluting balloon versus drug-eluting stent treatment of drug-eluting stent in-stent restenosis: A meta-analysis of available evidence.
    Bajraktari G; Jashari H; Ibrahimi P; Alfonso F; Jashari F; Ndrepepa G; Elezi S; Henein MY
    Int J Cardiol; 2016 Sep; 218():126-135. PubMed ID: 27232924
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent.
    Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Naganuma T; Sticchi A; Figini F; Latib A; Chieffo A; Carlino M; Montorfano M; Colombo A
    JACC Cardiovasc Interv; 2015 Jun; 8(7):900-9. PubMed ID: 26003020
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons.
    Zhang D; Sun Y; Liu X; Liu F; Cheng Y; Ma X; Zhao Y; Zhou Y
    Angiology; 2019 May; 70(5):414-422. PubMed ID: 30384776
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis.
    Nojima Y; Yasuoka Y; Kume K; Adachi H; Hattori S; Matsutera R; Kohama Y; Sasaki T
    Coron Artery Dis; 2014 Dec; 25(8):638-44. PubMed ID: 25076360
    [TBL] [Abstract][Full Text] [Related]  

  • 65. 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.
    Tamburino C; Capranzano P; Gori T; Latib A; Lesiak M; Nef H; Caramanno G; Naber C; Mehilli J; Di Mario C; Sabaté M; Münzel T; Colombo A; Araszkiewicz A; Wiebe J; Geraci S; Jensen C; Mattesini A; Brugaletta S; Capodanno D
    JACC Cardiovasc Interv; 2016 Mar; 9(5):440-9. PubMed ID: 26875648
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial (TWENTE II).
    Sen H; Lam MK; Löwik MM; Danse PW; Jessurun GA; van Houwelingen KG; Anthonio RL; Tjon Joe Gin RM; Hautvast RW; Louwerenburg JH; de Man FH; Stoel MG; van der Heijden LC; Linssen GC; IJzerman MJ; Tandjung K; Doggen CJ; von Birgelen C
    JACC Cardiovasc Interv; 2015 Jun; 8(7):889-99. PubMed ID: 26003019
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Choice of stenting strategy in true coronary artery bifurcation lesions.
    Lin QF; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL
    Coron Artery Dis; 2010 Sep; 21(6):345-51. PubMed ID: 20613498
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Single-stent crossover technique from distal unprotected left main coronary artery to the left circumflex artery.
    Naganuma T; Chieffo A; Basavarajaiah S; Takagi K; Costopoulos C; Latib A; Carlino M; Montorfano M; Bernelli C; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):757-64. PubMed ID: 23674385
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immediate results and long-term clinical outcome of patients with unprotected distal left main restenosis: the CORPAL registry (Córdoba and Las Palmas).
    Ojeda S; Pan M; Martín P; Mazuelos F; Suárez de Lezo J; Romero M; Segura J; Pavlovic D; Medina A; Suárez de Lezo J
    JACC Cardiovasc Interv; 2014 Feb; 7(2):212-221. PubMed ID: 24440026
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis.
    Hehrlein C; Richardt G; Wiemer M; Schneider H; Naber C; Hoffmann E; Dietz U
    EuroIntervention; 2011 May; 7 Suppl K():K119-24. PubMed ID: 22027721
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serial morphological and functional assessment of drug-eluting balloon for in-stent restenotic lesions: mechanisms of action evaluated with angiography, optical coherence tomography, and fractional flow reserve.
    Agostoni P; Belkacemi A; Voskuil M; Nathoe HM; Doevendans PA; Stella PR
    JACC Cardiovasc Interv; 2013 Jun; 6(6):569-76. PubMed ID: 23683736
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of clinical outcomes between first-generation and second-generation drug-eluting stents in type 2 diabetic patients.
    Jeong HS; Cho JY; Kim EJ; Yu CW; Ahn CM; Park JH; Hong SJ; Lim DS
    Coron Artery Dis; 2013 Dec; 24(8):676-83. PubMed ID: 23994881
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term clinical outcomes after treatment of stent restenosis with two drug-coated balloons.
    Schröder J; Vogt F; Burgmaier M; Reith S; Almalla M
    Coron Artery Dis; 2018 Dec; 29(8):632-637. PubMed ID: 30273183
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.
    Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I study.
    Worthley S; Hendriks R; Worthley M; Whelan A; Walters DL; Whitbourn R; Meredith I
    Cardiovasc Revasc Med; 2015; 16(7):413-7. PubMed ID: 26346023
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term comparison of everolimus-eluting and biolimus-eluting stents.
    Puricel S; Oberhänsli M; Guntern P; Lehmann S; Goy JJ; Arroyo D; Villeneuve H; Baeriswyl G; Stauffer JC; Togni M; Cook S
    EuroIntervention; 2013 Jul; 9(3):336-44. PubMed ID: 23482296
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Comparison of Clinical Outcomes After Drug-Eluting Balloon and Drug-Eluting Stent Use for Left Main Bifurcation In-Stent Restenosis.
    Lee WC; Hsueh SK; Chen CJ; Yang CH; Fang CY; Wu CJ; Fang HY
    Int Heart J; 2018 Sep; 59(5):935-940. PubMed ID: 30101849
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-term clinical outcomes following drug-eluting stent implantation for unprotected distal trifurcation left main disease: the Milan-New Tokyo (MITO) registry.
    Ielasi A; Takagi K; Latib A; Basavarajaiah S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Catheter Cardiovasc Interv; 2014 Mar; 83(4):530-8. PubMed ID: 23983065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.